BIOMEA FUSION INC. -
8.1800
08-November-24 14:59:59
15 minutes delayed
Stocks
0.0000
0.00%
Today's range
8.0300 - 8.4700
ISIN
N/A
Source
NASDAQ
-
27 Oct 2022 07:00:01 By Nasdaq GlobeNewswire
-
BMF-219 Enters the Clinic for KRAS Solid Tumors
14 Oct 2022 08:00:00 By Nasdaq GlobeNewswire
-
Biomea Fusion Reports Second Quarter 2022 Financial Results and Business Highlights
01 Aug 2022 15:05:01 By Nasdaq GlobeNewswire
-
Biomea Fusion Announces First Patient Dosed in Multiple Myeloma Cohort of COVALENT-101 Trial
22 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
04 Jun 2022 10:00:00 By Nasdaq GlobeNewswire
-
Biomea Fusion to Participate in Jefferies Healthcare Conference
02 Jun 2022 17:00:00 By Nasdaq GlobeNewswire
-
Biomea Fusion to Present New Preclinical Data on BMF-219 in Two Diabetic Animal Models at ADA 2022
01 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
26 May 2022 17:30:00 By Nasdaq GlobeNewswire
-
Biomea Fusion to Attend H.C. Wainwright Global Investment Conference
20 May 2022 12:30:00 By Nasdaq GlobeNewswire
-
19 May 2022 07:00:00 By Nasdaq GlobeNewswire
-
Biomea Fusion Reports First Quarter 2022 Financial Results and Business Highlights
16 May 2022 06:30:00 By Nasdaq GlobeNewswire
-
Biomea Fusion to Participate in Bank of America Securities 2022 Healthcare Conference
09 May 2022 15:30:00 By Nasdaq GlobeNewswire
-
Biomea Fusion Announces Acceptance of Multiple Abstracts at the 2022 ASCO Annual Meeting
27 Apr 2022 15:00:00 By Nasdaq GlobeNewswire
-
08 Apr 2022 12:00:00 By Nasdaq GlobeNewswire
-
06 Apr 2022 16:00:00 By Nasdaq GlobeNewswire
-
Biomea Fusion to Present at Oppenheimer’s 32nd Annual Virtual Healthcare Conference
15 Mar 2022 07:30:00 By Nasdaq GlobeNewswire